Epidemiology of arrhythmogenic ventricular cardiomyopathy in China
Clinical Cardiology · 2024
DOI: 10.1002/clc.24160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Si-Tong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Catheter Ablation, Tachycardia, Ventricular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Arrhythmogenic ventricular cardiomyopathy (AVC) is a common cause of ventricular arrhythmias and mortality, but limited data are available from large Asian cohorts. Our aim was to explore the current status of AVC and second, we examined the prevalence of ventricular tachycardia (VT), heart failure (HF) and mortality in patients with AVC in the Chinese population. Hypothesis At present, some studies have reported that the incidence of AVC is on the rise, which may be due to the increasing number of diagnostic methods for AVC. However, there is no epidemiological data on AVC in the Chinese population, so we speculate that the incidence of AVC in the Chinese population is increasing. Methods and Results We studied 15 888 adults from the Beijing Municipal Health Commission Information Center (BMHCIC) registry database in China from January 2010 to December 2020, and calculated the average annual percentage change (AAPC). Second, we determined the incidence of VT, HF and mortality in patients with AVC. Of the 10 318 men and 5570 women who were screened by cardiac magnetic resonance or examined by myocardial biopsy, there were a total of 256 newly diagnosed AVC patients (mean [SD]: 37.54[17.10]; 39.45% female). The incidence of AVC increased from 7.60 (3.12‐12.06) in 2010 to 19.62 (11.51‐27.75) per 1000 person‐years in 2020. Males had higher incidence of AVC than females. The AAPC for the rising incidence of AVC was 8.9 %. Males had similar VT prevalence (70.32% vs. 62.38%, p = 0.19) and mortality (1.94% vs. 1.98%, p = 0.98) but lower HF prevalence (42.58% vs. 60.40%, p = 0.006), when compared to females. Radiofrequency ablation (RFA) was more likely to be performed in males ( p = 0.006).
Conclusions
The rising trend in AVC incidence was evident, with two‐fold increase by 2020. Males with AVC had similar VT prevalence and mortality rate, but HF prevalence were lower than females, perhaps impacted by RFA use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Beijing Municipal Health Commission Information Center, Beijing, China.
- School of Electronic and Information Engineering, Beijing Jiaotong University, Beijing, China.
- School of Biomedical Engineering, Capital Medical University, Beijing, China.
- Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK.
ORCID-Profile: Gregory Y H Lip
Zitieren
APA
Liu, S. T., Li, R., Zheng, J. P., Lu, F., Sun, H. N., Hua, L., Lip, G. Y. H., Zhong, P., & Bai, Y. (2024). Epidemiology of arrhythmogenic ventricular cardiomyopathy in China. Clinical Cardiology. https://doi.org/10.1002/clc.24160
Vancouver
Liu ST, Li R, Zheng JP, Lu F, Sun HN, Hua L, et al. Epidemiology of arrhythmogenic ventricular cardiomyopathy in China. Clinical Cardiology. 2024. doi:10.1002/clc.24160
BibTeX
@article{Liu2024,
author = {Liu, Si-Tong and Li, Rui and Zheng, Jian-Peng and Lu, Feng and Sun, Hui-Ni and Hua, Lin and Lip, Gregory Y H and Zhong, Peng and Bai, Ying},
title = {Epidemiology of arrhythmogenic ventricular cardiomyopathy in China},
journal = {Clinical Cardiology},
year = {2024},
doi = {10.1002/clc.24160}
}
EUVIMED